Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35) - Image 1

Price loading...

Springer Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Name: Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)
Brand: Springer

Pharmacy - Dispensing

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

The biotechnology/biopharmaceutical sector has tremendously grown which led to the invention of engineered antibodies such as Antibody Drug Conjugates (ADCs), Bispecific T-cell engager (BITES), Dual Variable Domain (DVD) antibodies, and fusion proteins that are currently being used as therapeutic agents for immunology, oncology and other disease conditions. Regulatory agencies have raised the bar for the development and manufacture of antibody-based products, expecting to see the use of Quality by Design (QbD) elements demonstrating an in-depth understanding of product and process based on sound science. Drug delivery systems have become an increasingly important part of the therapy and most biopharmaceuticals for self-administration are being marketed as combination products. A survey of the market indicates that there is a strong need for a new book that will provide “one stop shopping” for the latest information and knowledge of the scientific and engineering advances madeover the last few years in the area of biopharmaceutical product development. The new book entitled Development of Biopharmaceutical Drug Device Products is a reference text for scientists and engineers in the biopharmaceutical industry, academia or regulatory agencies. With insightful chapters from experts in the field, this new book reviews first principles, covers recent technological advancements and provides case studies and regulatory strategies relating to the development and manufacture of antibody-based products. It covers topics such as the importance of early preformulation studies during drug discovery to influence molecular selection for development, formulation strategies for new modalities, and the analytical techniques used to characterize them. It also addresses important considerations for later stage development such as the development of robust formulations and processes, including process engineering and modeling of manufacturing unit operations, the design of analytical comparability studies, and characterization of primary containers (pre-filled syringes and vials).Finally, the latter half of the book reviews key considerations to ensure the development and approval of a patient-centered delivery system design. This involves the evolving regulatory framework with perspectives from both the US and EU industry experts, the role of international standards, design control/risk management, human factors and its importance in the product development and regulatory approval process, as well as review of the risk-based approach to bridging between devices used in clinical trials and the to-be-marketed device. Finally, case studies are provided throughout.The typical readership would have biology and/or engineering degrees and would include researchers, scientific leaders, industry specialists and technology developers working in the biopharmaceutical field.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3030314146
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 14 March 2020
Listed Since: 15 August 2019

Barcode

No barcode data available

Springer Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Price History & Forecast

No Price Data Available

Price Distribution

Description

Product Specifications

Barcode

Similar Products You Might Like

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Challenges in Protein Product Development: 38 (AAPS Advances in the Pharmaceutical Sciences Series, 38)

Wiley - Biological Drug Products: Development and Strategies

Sterile Product Development: Formulation, Process, Quality and Regulatory Considerations: 6 (AAPS Advances in the Pharmaceutical Sciences Series, 6)

Academic Press Biotherapeutics Formulation and Device Management

Quality by Design for Biopharmaceutical Drug Product Development: 18 (AAPS Advances in the Pharmaceutical Sciences Series, 18)

Biopharmaceuticals: Challenges and Opportunities

Biopharmaceutics Applications in Drug Development

Springer Biobetters: Protein Engineering to Approach the Curative

Development of Biopharmaceutical Parenteral Dosage Forms: 085 (Drugs and the Pharmaceutical Sciences)

Drug Product Development for the Back of the Eye: 2 (AAPS Advances in the Pharmaceutical Sciences Series, 2)

Current Applications of Pharmaceutical Biotechnology: 171 (Advances in Biochemical Engineering/Biotechnology, 171)

Current Applications of Pharmaceutical Biotechnology: 171 (Advances in Biochemical Engineering/Biotechnology, 171)

Quality by Design for Biopharmaceutical Drug Product Development: 18 (AAPS Advances in the Pharmaceutical Sciences Series, 18)

Translating Molecules into Medicines: Cross-Functional Integration at the Drug Discovery-Development Interface: 25 (AAPS Advances in the Pharmaceutical Sciences Series, 25)

Basic Principles of Drug Discovery and Development

Integrated Safety and Risk Assessment for Medical Devices and Combination Products

Detection and Quantification of Antibodies to Biopharmaceuticals: Practical and Applied Considerations

Drug Development for Gene Therapy: Translational Biomarkers, Bioanalysis, and Companion Diagnostics

Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications

Regulated Bioanalysis: Fundamentals and Practice: 26 (AAPS Advances in the Pharmaceutical Sciences Series, 26)

Integrated Safety and Risk Assessment for Medical Devices and Combination Products

Monoclonal Antibodies: Meeting the Challenges in Manufacturing, Formulation, Delivery and Stability of Final Drug Product

Developability of Biotherapeutics: Computational Approaches